At a meeting between the representatives of Rorer Healthcare and the DHSS, the DHSS accepted that the data on viral inactivation presented did look in favour of the heat treatment process. However due to two cases of seroconversion despite heat treatment the DHSS would look carefully to decide if it were necessary to make the company voluntarily withdraw the product.